Completed PHASE4 INTERVENTIONAL 8-arm NCT00232492

Ketamine on Acute Pain in Females and Males

Effect of Racemic Ketamine on Pain in Females and Males After Surgical Removal of Third Molars

Sponsor: Ullevaal University Hospital

Conditions Mouth and Tooth Diseases Tooth, Impacted

Interventions Ketamine 0,1 mg/kg females Ketamine 0,1 mg/kg males Ketamine 0,3 mg/kg females Ketamine 0,3 mg/kg males Ketamine 0,5 mg/kg females Ketamine 0,5 mg/kg males Placebo females Placebo males

Updated 6 times since 2017 Last updated: Jul 3, 2011 Started: Jan 31, 2005 Primary completion: Nov 30, 2006 Completion: Nov 30, 2006

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Mouth and Tooth Diseases and Tooth, Impacted, this trial is completed. The trial is conducted by Ullevaal University Hospital and has accumulated 6 data snapshots since 2005. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Feb 2017 — Jun 2018 [monthly]

Completed PHASE4

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Completed PHASE4

First recorded

Jan 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Ullevaal University Hospital
University of Oslo

Data source: Oslo University Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Oslo, Norway